Are diabetic men and women treated equally? A population-based study

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 11, Issue 1, 1998, Pages 8-16

  Wredling, R ^a,e   Adamson, U ^b   Ostman J ^c   Ericsson, A ^d   Larsson, Y ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

^c NATIONAL BOARD OF HEALTH AND WELFARE   (Sweden)

^d Swedish Medical Association   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Gender; Outcome; Priorities; Type I diabetes; Type II diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN; SULFONYLUREA; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; COMPETENCE; DIABETES MELLITUS; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; HOME CARE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICIAN; PRIORITY JOURNAL; QUESTIONNAIRE; SEX DIFFERENCE; STAFF; SWEDEN; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031704928     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Haaber A.B., Kofoed-Enevoldsen A., Jensen T.: The prevalence of hypercholesterolaemia and its relationship with albuminuria in insulin-dependent diabetic patients: an epidemiological study. Diabetic Med. 9: 557-561, 1992.
2. UK Prospective Diabetes Study Group (HDS): I.: Prevalence of hypertension in newly presenting Type II diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J. Hypertens. 11: 309-317, 1993.
3. UK Prospective Diabetes Study Group (HDS): II.: Increased risk of cardiovascular complications in hypertensive Type II diabetic patients. J. Hypertens. 11: 319-325, 1993.
4. DCCT Research Group.: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329: 977-986, 1993.
5. Manley S.E.: UK Prospective Diabetes Study Group: UK Prospective Diabetes Study Group (UKPDS) XI: Biomedical risk factors in Type II diabetic patients at diagnosis compared with age-matched normal subjects. Diabetic Med. 11: 534-544, 1994.
6. Stephenson J., Fuller J.H.: Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications study. Diabetologia 37: 278-285, 1994.
7. Krolewski A.F., Laffel L., Krolewski M., Quinn M., Warram J.H.: Glycosylated haemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N. Engl. J. Med. 332: 1251-1255, 1995.
8. Andersson D.K.G., Svàrdsudd K., Tibblin G.: Prevalence and incidence of diabetes in a Swedish community 1972-1978. Diabetic Med. 8: 428-434, 1991.
9. Aspects of the world-wide epidemiology of diabetes mellitus and its long-term complications. (Eds). Ekoe J-M. Elsevier Science Publishers BV, 1988, pp. 33-171.
10. Blohmé G., Nyström L., Arnqvist H., Lithner F., Littorien B., Olsson P.-O., Schersten B., Wibell L., Östman J.: Male predominance of Type I (insulin-dependent) diabetes mellitus in young adults: results from a 5-year prospective nationwide study of the 15-34 year age group in Sweden. Diabetologia 35: 56-62, 1992.
11. Karvonen M., Tuomiletho J., Libman I., La Porte R., for the World Health Organization DIAMOND Project Group: A review of the epidemiological data on the world-wide incidence of Type I (insulin-dependent) diabetes mellitus. Diabetologia 36: 883-892, 1993.
12. Krans H.M.J., Porta M., Keen H. (Eds). EuroDIABCARE, Diabetes care and research in Europe: The St Vincent Declaration Action Programme. Implementation Document. WHO Regional office for Europe. Copenhagen 1992.
13. Larsson Y., Wredling R., Adamson U., Ericsson A., Nilsson B., Östman J.: Quality of diabetes care in four counties in Sweden. Diab. Nutr. Metab. 6: 321-324, 1993.
14. Berne C., Adamson U., Dahlén M., Ericsson A., Larsson Y., Nilsson B., Stålhammar J., Wredling R., Östman J.: A population-based quality assurance project in two Swedish counties: Experience with the DIABCARE Basic Information Sheet. Diab. Nutr. Metab. 3: 325-328, 1993.
15. Wredling R., Adamson U., Ericsson A., Larsson Y., Östman J.: Patients' opinions in diabetes care in relation to glycaemic control. Pract. Diab. Internat. 13: 80-82, 1996.
16. Wredling R., Adamson U., Berne C., Dahlén M., Östman J., Larsson Y., Stålhammar J.: Quality of life among a representative sample of people with diabetes mellitus in Sweden. Diab. Nutr. Metab. 6: 393-395, 1993.
17. Wredling R., Stålhammar J., Adamson U., Berne C., Larsson Y., Östman J.: Well-being and treatment satisfaction in adults with diabetes: A Swedish population-based study. Qual. Life Res. 4: 515-522, 1995.
18. Bradley C.: Handbook of psychology and diabetes. Harwood Academic Publishers, London 1994.
19. Piwernetz K., Home P.D., Snorgaard O., Antsiferov M., Staher-Johansen K., Krans M.: Monitoring the targets of the St Vincent Declaration and the implementation of quality management in diabetes care: the DIABCARE initiative. Diabetic Med. 10: 371-377, 1993.
20. Fischer U., Salzsieder E., Menzel R., Vogt L., Röpke H., Schmidt R., Heinke P.: Primary health care of diabetic patients in a specialized outpatient setting: a DIABCARE-based analysis. Diabetes Metab. 19: 188-194, 1993.
21. Gardner MJ., Altman D. G.: Statistics with confidence. Confidence interval and statistical guidelines. Br. Med. J., Tavistock Square, London 1995.
22. Folkpensionsanstaltens publikationer (Eds) Diabetes-läkemedel i Norden - Analys av orsaker till variationer i förbrukningen. ML 105, Helsingfors, 1991, pp. 52-53.
23. European IDDM Policy Group. Consensus guidelines for the management of insulin-dependent (Type I) diabetes. International Diabetes Federation. Brussels, 1993.
24. Pyöräla K., Pedersen T.R., Kjekshus J., Faegerman O., Olsson A. G., Thorgeirsson G.: Cholesterol lowering with Simvastatin improves prognosis of diabetic patients with coronary heart disease. Diabetes Care 20: 614-620, 1997.
25. Gates G.: Dyslipidemias in diabetic patients. Is standard cholesterol treatment appropriate? Postgrad. Med. 95: 69-84, 1994.
26. Falck A.A.K., Käär M.-L., Laatikainen L.T.: Prevalence and risk factors of retinopathy in children with diabetes. A population-based study on Finnish children. Acta Ophthalmol. 71: 801-809, 1993.
27. Jerneld B., Algvere P.: The prevalence of retinopathy in insulin-dependent juvenile-onset diabetes mellitus - a fluorescein-angiographic study. Acta Ophthalmol. 62: 617-630, 1984.
28. Trauter C., Icks A., Haastert B., Plum F., Berger M.: Incidence of blindness in relation to diabetes. Diabetes Care 20: 1147-1153, 1997.
29. Franck R.N., Hoffman W.H., Podgor M.J., Joondeph H.C., Lewis R.A., Margherio R.R., Nachazel D.P., Weiss H., Cristopherson K.W., Croin M.A.: Retinopathy in juvenile-onset Type I diabetes of short duration. Diabetes 31: 874-882, 1982.
30. Danielsson R., Helgason T., Jónasson F.: Prognostic factors and retinopathy in Type I diabetics in Iceland. Acta. Med. Scand. 213: 323-326, 1983.
31. Klein R., Klein B.E.K., Moss S.E., Davis M.D., DeMets D.L.: The Visconsin epidemiologic study of diabetic retinopathy. Arch. Ophthalmol. 102: 520-526, 1984.
32. Orchard T.J., Dorman J.S., Maser R.E., Becker D.J., Drash A.L., Ellis D., LaPorte R.E., Kuller L.H.: Prevalence of complications in CDDM by sex and duration. Diabetes 39: 1116-1124, 1990.
33. Joner G., Brinchmann-Hansen O., Torres C.G., Hanssen K.F.: A nationwide cross-sectional study of retinopathy and microalbuminuria in young Norwegian Type I (insulin-dependent) diabetic patients. Diabetologia 35: 1049-1054, 1992.
34. Kullberg C.E., Amqvist H.J.: Elevated long-term glycosylated haemoglobin precedes proliferative retinopathy and nephropathy in Type I (insulin-dependent) diabetic patients. Diabetologia 36: 961-965, 1993.
35. Marshall G., Garg S.K., Jackson W.E., Holmes D.L., Chase H.P.: Factors influencing the onset and progression of diabetic retinopathy in subjects with insulin-dependent diabetes mellitus. Ophthalmology 100: 1133-1139, 1993.
36. Llyod C.E., Becker D., Ellis D., Orchard T.J.: Incidence of complications in insulin-dependent diabetes mellitus: a survival analysis. Am. J. Epidemiol. 143: 431-441, 1996.
37. Kernell A., Dedorsson L, Johansson B., Wickström C.P., Ludviqsson J., Tuvemo T., Neiderud J., Sjöström K., Malmgren K., Kanulf P., Mellvig L., Gjötterberg M., Sule J., Persson L.Å., Larsson L.I., Åman J., Dahlquist G.: Prevalence of diabetic retinopathy in children and adolescents with IDDM. A population-based multicentre study. Diabetologia 40: 307-310, 1997.
38. Slide A., Moos R.H., Adams J., Cady P.: Development of a coping scale. Arch. Gen. Psychiatry 20: 226-232, 1969.
39. Billings A.G., Moos R.H.: Life Stressors and social resources affect posttreatment outcomes among depressed patients. J. Abnorm. Psychol. 94: 140-153, 1985.